Strategic PartnershipsThe partnership with Avion enhances Opyl's market validation and strengthens its position in the biotech industry by leveraging data-driven approaches to improve clinical trial outcomes.

AI InnovationsOpyl's focus on AI innovations and strategic partnerships positions it as a leader in biotech, enhancing its market presence and driving long-term growth through advanced clinical trial solutions.

Capital RaisingThe successful capital raise reflects strong investor confidence in Opyl's AI platform, providing financial resources to expand its capabilities and market reach, supporting sustainable growth.

Bears Say

Revenue DeclineThe sharp revenue decline highlights financial instability and challenges in sustaining operations, necessitating strategic adjustments to improve financial health and ensure long-term viability.

Financial InstabilityNegative equity and financial distress suggest significant solvency issues, posing risks to Opyl's operational capabilities and long-term sustainability without corrective measures.

Cash Flow ChallengesNegative cash flows from operations indicate poor cash conversion efficiency, limiting Opyl's ability to fund growth initiatives and maintain financial stability without external financing.

Opyl Ltd. News

Pathkey.ai Awards 4 Million Incentive Options to Director Shannon Robinson

Opyl Ltd. ( ($AU:PKY) ) has shared an announcement. Pathkey.ai Ltd has granted director Shannon Robinson 4 million...

13d ago

PKY

Pathkey.ai Issues 4 Million Unquoted Options Under Employee Incentive Scheme

Opyl Ltd. ( ($AU:PKY) ) has issued an announcement. Pathkey.ai Ltd has notified the market of the issue...

13d ago

PKY

Pathify.ai Director Increases Indirect Shareholding Through Placement

Opyl Ltd. ( ($AU:PKY) ) has shared an announcement. Pathify.ai Ltd has disclosed a change in director Paul...

16d ago

PKY

PathKey.AI lodges cleansing notice for new share issue

The latest announcement is out from Opyl Ltd. ( ($AU:PKY) ). The company lodged a cleansing notice confirming...

18d ago

PKY

Pathkey.AI Seeks ASX Quotation for Over 10 Million New Shares

Opyl Ltd. ( ($AU:PKY) ) has issued an update. Pathkey.AI Ltd has applied to the Australian Securities Exchange...

18d ago

PKY

PathKey.AI Issues 175.5 Million Unquoted Options Across Three New Classes

An update from Opyl Ltd. ( ($AU:PKY) ) is now available. PathKey.AI Ltd has notified the market of...

18d ago

PKY

PathKey.AI Seeks ASX Quotation for 48.7 Million Ordinary Shares

Opyl Ltd. ( ($AU:PKY) ) just unveiled an announcement. PathKey.AI Ltd has lodged an Appendix 2A with the...

18d ago

PKY

Pathkey.ai Seeks Quotation for 5 Million New Shares

Opyl Ltd. ( ($AU:PKY) ) has issued an announcement. Pathkey.ai operates in the artificial intelligence and data analytics...

18d ago

PKY

Opyl Updates Proposed Securities Issue and Option Terms

The latest announcement is out from Opyl Ltd. ( ($AU:PKY) ). Opyl Ltd (PATHKEY.AI Ltd, ASX: PKY) has...

18d ago

PKY

Opyl Trims Share Placement to Sandton Capital Advisory

Opyl Ltd. ( ($AU:PKY) ) has shared an update. Opyl Ltd has updated its planned capital raise, scaling...

18d ago

PKY

PKY FAQ

What was Opyl Ltd.’s price range in the past 12 months?

Opyl Ltd. lowest share price was AU$0.01 and its highest was AU$0.03 in the past 12 months.

What is Opyl Ltd.’s market cap?

Opyl Ltd.’s market cap is AU$18.21M.

When is Opyl Ltd.’s upcoming earnings report date?

Opyl Ltd.’s upcoming earnings report date is Mar 02, 2026 which is in 8 days.

How were Opyl Ltd.’s earnings last quarter?

Currently, no data Available

Is Opyl Ltd. overvalued?

According to Wall Street analysts Opyl Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Opyl Ltd. pay dividends?

Opyl Ltd. does not currently pay dividends.

What is Opyl Ltd.’s EPS estimate?

Opyl Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Opyl Ltd. have?

Opyl Ltd. has 607,077,760 shares outstanding.

What happened to Opyl Ltd.’s price movement after its last earnings report?

Currently, no data Available

Which hedge fund is a major shareholder of Opyl Ltd.?

Currently, no hedge funds are holding shares in AU:PKY

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Opyl Ltd. Stock Smart Score

Outperform

Insider Transactions

Bought Shares

Worth AU$24.0K over
the Last 3 Months

Technicals

Top Smart Score Stocks >

Company Description

Opyl Ltd.

Pathkey.AI Ltd, a digital health company, involves artificial intelligence (AI) to improve clinical trials and predicting outcomes for patients in Australia. The company offers TrialKey, an AI-driven clinical trial optimization and success prediction platform, that simulate and optimize trial designs. It also provides TrialGen, an AI-powered tool streamlines clinical trial design process. The company serves biopharma, MedTech, government, and healthcare organizations. The company was formerly known as Opyl Limited and changed its name to Pathkey.AI Ltd in August 2025. Pathkey.AI Ltd was incorporated in 1994 and is based in Sydney, Australia.